ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates.

The BeLPT has high specificity for identifying chronic beryllium disease but poor sensitivity in distinguishing it from sarcoidosis.

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although ...

Tyr Pharma (ATYR) announced topline results from the Phase 3 EFZO-FIT study of efzofitimod in 268 patients with pulmonary sarcoidosis, a major ...

Sarcoidosis, an inflammatory disease characterized by granuloma formation, affects various organs, most commonly the lungs.

Pulmonary endarterectomy surgery may more effectively improve pulmonary circulation and heart function for CTEPH than BPA, a ...

Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report in the September 10 online issue of ...

Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH), a rare lung ...

Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine ...

Lung tumors don’t just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report in the September 10 online issue of ...

University of Colorado Cancer Center member D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, ...

Corvista Health’s point-of-care device can detect cases of PH that other testing methods miss, according to a recent case ...